IP Library › Assignment 025532/0740
Patent Assignment
Reel/Frame 025532/0740

Merger

Recorded: 2010-12-21 Pages: 5
Assignor
TRUBION PHARMACEUTICALS, INC.
Executed: 2010-10-28
Assignee
EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
2401 FOURTH AVENUE, SUITE 1050, SEATTLE, WASHINGTON, 98121
Covered Property (1)
Materials and Methods for Improved Immunoglycoproteins
Patent: 8,383,106 →
Application: 12/909,769 →
Publication: US 2011/0256125
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 12, 2010
From: BAUM, PETER ROBERT; ESPLING, ERIK STEPHEN; THOMPSON, PETER ARMSTRONG
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 025356/0526 →
Change of Name Jul 18, 2016
From: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
To: APTEVO RESEARCH AND DEVELOPMENT LLC
Reel/Frame 039382/0985 →
Security Interest Feb 7, 2019
From: APTEVO THERAPEUTICS INC.; APTEVO BIOTHERAPEUTICS INC.; APTEVO RESEARCH AND DEVELOPMENT LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 048270/0813 →
Release of Security Interest Mar 6, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: APTEVO THEAPEUTICS INC.; APTEVO BIOTHERAPEUTICS LLC; APTEVO RESEARCH AND DEVELOPMENT LLC
Reel/Frame 052039/0258 →